Bactiguard Holding (BACTI-B.ST) Stock Analysis & AI Equity Report

Medical - Equipment & Services SEK Explore free reports

Bactiguard Holding (BACTI-B.ST) overview

Bactiguard Holding (BACTI-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Bactiguard Holding reported revenue of SEK 216m and operating profit of SEK -9.4m; the year-end share price was 19.90 SEK and market capitalisation was SEK 697m. Bactiguard Holding is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Bactiguard Holding's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueSEK 315mFY 2025
Share price19.90 SEKFY 2025 year end
RevenueSEK 216mFY 2025
Operating profitSEK -9.4mFY 2025
Net earningsSEK -7.8mFY 2025
Market capitalisationSEK 697mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Bactiguard Holding

Bactiguard Holding AB develops and licenses a biocompatible coating technology for medical devices that helps prevent device-related infections by reducing bacterial adhesion and biofilm formation. Through partnerships with global MedTech companies, it applies the technology to products such as catheters and other devices, and it also offers a smaller wound care portfolio.

Generate the Bactiguard Holding report

Bactiguard Holding is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Bactiguard Holding and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Bactiguard Holding

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.